Cor Vasa 2013, 55(4):e286-e292 | DOI: 10.1016/j.crvasa.2013.03.007

The importance of admission and discharge BNP assessment in patients hospitalized for acutely decompensated chronic systolic heart failure

Ondřej Ludkaa,e,*, Roman Štípala, Marta Šenkyříkováa, Viktor Musila, Jan Trnab, Zbyněk Pozdíšekc, Jiří Jarkovskýd, Ladislav Dušekd, Jindřich Špinara,e
a Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
b Interní gastroenterologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
c Kardiochirurgická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika
d Institut biostatistiky a analýz Lékařské a Přírodovědecké fakulty Masarykovy univerzity, Brno, Česká republika
e International Clinical Research Center, Brno, Česká republika

Introduction: The assessment of B-type natriuretic peptide (BNP) plasma levels is not only useful for the differential diagnosis of acute dyspnea, but also for the prognostic stratification of patients with heart failure. However, available studies that have addressed monitoring of hospitalized patients are burdened with significant limitations: 1) measurement of plasma BNP levels only at admission or at discharge, 2) lack of details regarding the cause of heart failure, 3) small sample size. Therefore, we conducted a prospective study of all patients presenting to our hospital with acutely decompensated chronic systolic heart failure.

Aim: To determine the importance of admission and discharge values of BNP and its changes during hospitalization for identification of patients with acutely decompensated chronic systolic heart failure at higher risk of unfavorable course of the disease.

Methods: A prospective monocentric study determining plasma BNP levels at admission and at discharge in patients hospitalized for acutely decompensated chronic systolic heart failure.
Patients: 130 consecutive patients, 77% men, mean age 70 years, body mass index (BMI) 27.8 kg/m2, etiology of chronic heart failure - 65.9% ischemic heart disease, 29.5% dilated cardiomyopathy, 4.6% others, signs and symptoms at admission - peripheral edema 58.9%, pulmonary rales 88.3%, orthopnea 53.1%, median of admission BNP 1 101 pg/ml, median of discharge BNP 650 pg/ml, median left ventricular ejection fraction 26.5%, average length of hospitalization 9 days.

Results: During the follow-up (mean 15 months) the total mortality rate reached almost 40% and the annual mortality of our cohort was 29%. The most common causes of death included progression of heart failure and acute coronary syndromes. To evaluate the long-term risk of mortality, we used time-dependent ROC curves for the definition of cut-off values of BNP at admission and discharge. The relationship of BNP levels and the survival of patients was assessed using the hazard ratio (HR) calculated by the Cox proportional hazards model. BNP at admission and at discharge with a cut-off value of 1 699 pg/ml and 434.5 pg/ml are significant prognostic factors for patients hospitalized for acutely decompensated chronic systolic heart failure with a HR 2.79 and 3.29, respectively. During the follow-up, more than half of patients required readmission to hospital. The most common reasons for rehospitalization were cardiovascular causes.

Conclusion: BNP levels at admission and at discharge are an important predictive factor of survival in patients with acutely decompensated chronic systolic heart failure.

Keywords: Admission and discharge BNP level; Heart failure; Prognosis

Received: December 7, 2012; Revised: March 11, 2013; Accepted: March 18, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ludka O, Štípal R, Šenkyříková M, Musil V, Trna J, Pozdíšek Z, et al.. The importance of admission and discharge BNP assessment in patients hospitalized for acutely decompensated chronic systolic heart failure. Cor Vasa. 2013;55(4):e286-292. doi: 10.1016/j.crvasa.2013.03.007.
Download citation

References

  1. P.A. McCullough, E.F. Philbin, J.A. Spertus, et al., Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study, Journal of the American College of Cardiology 39 (1) (2002) 60-69. Go to original source... Go to PubMed...
  2. M.W. Rich, Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults, Journal of the American Geriatric Society 45 (8) (1997) 968-974. Go to original source... Go to PubMed...
  3. J. McMurray, T. McDonagh, C.E. Morrison, et al., Trends in hospitalization for heart failure in Scotland 1980-1990, European Heart Journal 14 (9) (1993) 1158-1162. Go to original source... Go to PubMed...
  4. M.R. Cowie, A. Mosterd, D.A. Wood, et al., The epidemiology of heart failure, European Heart Journal 18 (2) (1997) 208-225. Go to original source... Go to PubMed...
  5. G.C. Fonarow, K.F. Adams Jr, W.T. Abraham, et al., Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, Journal of the American Medical Association 293 (5) (2005) 572-580. Go to original source... Go to PubMed...
  6. F. Zannad, A. Mebazaa, Y. Juillière, et al., Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study, European Journal of Heart Failure 8 (7) (2006) 697-705. Go to original source... Go to PubMed...
  7. K.K. Ho, J.L. Pinsky, W.B. Kannel, D. Levy, The epidemiology of heart failure: the Framingham study, Journal of the American College of Cardiology 22 (4 Suppl A) (1993) 6A-13A. Go to original source... Go to PubMed...
  8. J. Koglin, S. Pehlivanli, M. Schwaiblamir, et al., Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure, Journal of the American College of Cardiology 38 (2001) 1934-1941. Go to original source... Go to PubMed...
  9. P.S. Bettencourt, A. Azevedo, J. Pimenta, et al., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients, Circulation 110 (2004) 2168-2174. Go to original source... Go to PubMed...
  10. V. Cheng, R. Kazanegra, A. Garcia, et al., A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study, Journal of the American College of Cardiology 37 (2001) 386-391. Go to original source... Go to PubMed...
  11. D. Logeart, G. Thabut, P. Jourdain, et al., Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure, Journal of the American College of Cardiology 43 (4) (2004) 635-641. Go to original source... Go to PubMed...
  12. A. Gonçalves, A. Azevedo, R. Almeida, et al., Left ventricular systolic function in the prognosis of patients hospitalized due to worsening heart failure, Revista Portuguesa de Cardiologia 27 (2) (2008) 177-182. Go to PubMed...
  13. R. Latini, S. Masson, I. Anand, et al., Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial, Circulation 106 (2002) 2454-2458. Go to original source... Go to PubMed...
  14. D.R. Murdoch, T.A. McDonagh, J. Byrne, et al., Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy, American Heart Journal 138 (1999) 1126-1132. Go to original source... Go to PubMed...
  15. M.F. Rousseau, O. Gurne, D. Duprez, et al., Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy, Journal of the American College of Cardiology 40 (2002) 1596-1601. Go to original source... Go to PubMed...
  16. J.W. Fung, C.M. Yu, G. Yip, et al., Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in heart failure, American Journal of Cardiology 92 (2003) 406-410. Go to original source... Go to PubMed...
  17. T. Tsutamoto, A. Wada, H. Sakai, et al., Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure, Journal of the American College of Cardiology 47 (2006) 582-586. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.